Regarding the clinical role of GAL1 expression in bladder cancer, Wu et al. demonstrated that overexpression of GAL1 in bladder tumors was significantly associated with higher pathological T grade and nodal stage as well as an increased risk of disease recurrence [25]. This evidence concerns the gene LGALS1 and urinary bladder carcinoma.